Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TraceIT TM Hydrogel Tissue Marker for Patients Receiving Definitive Chemoradiation for Bladder Cancer

NCT03125226 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03125226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03125226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TraceIT TM Hydrogel Tissue Marker for Patients Receiving Definitive Chemoradiation for Bladder Cancer
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
October 5, 2017
Completion date
May 18, 2020
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder carcinoma